Literature DB >> 17475915

No screening yet after a negative test for the family mutation.

M M A Tilanus-Linthorst.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17475915      PMCID： PMC2597985          DOI： 10.1136/jmg.2006.048785

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  4 in total

1.  Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancer.

Authors:  M M A Tilanus-Linthorst; C Alves; C Seynaeve; M B E Menke-Pluymers; A M M Eggermont; C T M Brekelmans
Journal:  Br J Surg       Date:  2006-08       Impact factor: 6.939

2.  Selection bias influences reported contralateral breast cancer incidence and survival in high risk non-BRCA1/2 patients.

Authors:  Madeleine M A Tilanus-Linthorst; Karina C M Bartels; Celina Alves; Bonnie Bakri; Ellen Crepin; Ans van den Ouweland; Jan G M Klijn; Hanne Meijers-Heijboer; Cecile T M Brekelmans
Journal:  Breast Cancer Res Treat       Date:  2006-01       Impact factor: 4.872

3.  Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer.

Authors:  I Griebsch; J Brown; C Boggis; A Dixon; M Dixon; D Easton; R Eeles; D G Evans; F J Gilbert; J Hawnaur; P Kessar; S R Lakhani; S M Moss; A Nerurkar; A R Padhani; L J Pointon; J Potterton; D Thompson; L W Turnbull; L G Walker; R Warren; M O Leach
Journal:  Br J Cancer       Date:  2006-10-09       Impact factor: 7.640

4.  Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening.

Authors:  A Smith; A Moran; M C Boyd; M Bulman; A Shenton; L Smith; R Iddenden; E R Woodward; F Lalloo; E R Maher; D G R Evans
Journal:  J Med Genet       Date:  2006-11-01       Impact factor: 6.318
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.